Cargando…
Astragaloside IV protects human cardiomyocytes from hypoxia/reoxygenation injury by regulating miR-101a
Astragaloside IV (AS/IV) is one of the extracted components from the traditional Chinese medicine Astragalus which has been demonstrated to have potential capacity for anti-inflammation activity and for treating cardiovascular disease. Our purpose was to determine the function and underlying molecul...
Autores principales: | Wu, Yang, Fan, Zongjing, Chen, Zhengju, Hu, Jiqiang, Cui, Jie, Liu, Yang, Wang, Yao, Guo, Bin, Shen, Juan, Xie, Liandi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272390/ https://www.ncbi.nlm.nih.gov/pubmed/32394311 http://dx.doi.org/10.1007/s11010-020-03743-5 |
Ejemplares similares
-
Astragaloside IV attenuates hypoxia/reoxygenation injury-induced apoptosis of type II alveolar epithelial cells through miR-21-5p
por: Li, Hang, et al.
Publicado: (2021) -
MiR-499 inhibited hypoxia/reoxygenation induced cardiomyocytes injury by targeting SOX6
por: Shi, Yujie, et al.
Publicado: (2019) -
Astragaloside IV protects cardiomyocytes against hypoxia injury via HIF-1α and the JAK2/STAT3 pathway
por: Li, Bei, et al.
Publicado: (2021) -
Overexpression of miR-375 Protects Cardiomyocyte Injury following Hypoxic-Reoxygenation Injury
por: Ali Sheikh, Md Sayed
Publicado: (2020) -
Adiponectin Protects Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Suppressing Autophagy
por: Guo, Jia, et al.
Publicado: (2022)